Use of Depression, Anxiety and Stress Scale-21 (DASS-21) for the Evaluation of Oncological Patients
DOI:
https://doi.org/10.21270/archi.v13i7.5908Keywords:
Depression, Anxiety, Psychological Distress, NeoplasmsAbstract
Introduction: The Depression anxiety and stress scale-21 (DASS-21) assesses symptoms of depression, anxiety and stress; this scale was developed by Lovibond and Lovibond and initially contained 42 questions; the questions were reviewed and currently has 21 questions. When conducting a search in databases such as Pubmed, Science Direct, BVS and PsycINFO, little literature was observed using the Dass-21 scale with cancer patients. Objective: Research was to apply the DASS-21 scale to assess the symptoms of depression, anxiety and stress in cancer patients and to verify which of these symptoms has the highest prevalence among the participants evaluated by this study. Materials and methods: The scale was applied before antineoplastic treatment in a university clinical research center. This article is a field study, cross-sectional with a sample established by convenience, and the analysis performed on the collected data was descriptive. Results: 94 participants were evaluated, diagnosed with oncological disease. The participants in this research showed more symptoms of anxiety, followed by stress and finally by depression. Conclusion: Based on the research, it can be concluded that the predominant symptom among cancer patients is anxiety, which is a limiting factor for quality of life.
Downloads
References
Lovibond PF, Lovibond SH. The structure of negative emotional states: comparison of the depression anxiety stress scales (DASS) with the Beck depression and anxiety inventories. Behav Res Ther. 1995;33 (3):335-43.
Vignola RC, Tucci AM. Adaptation and validation of the depression, anxiety and stress scale (DASS) to brazilian portuguese. J affect disord. 2014;155:104–9.
Apóstolo JL, Mendes AC, Azeredo ZA. Adaptação para a língua portuguesa da Depression, Anxiety and Stress Scale (DASS). Rev latinoaml enferm. 2006;14(6)
McMullen M, Peter KH, Taylor S, McTigue J, Cook A, Hasani A, et al. Factors associated with psychological distress amongst outpatient chemotherapy patients: An analysis of depression, anxiety and stress using the DASS-21. Appl Nurs Res. 2018,40:45-50
Duarte BG, Maciel AP, Gonçalves ES, Santos PS. Avaliação perioperatória de indivíduos em quimioterapia com necessidade de intervenção cirúrgica odontológica. Arq méd hosp Fac Ciênc Méd Santa Casa de São Paulo. 2018;63(2):105-9.
Brasil. Instituto Nacional do Câncer José Alencar Gomes da Silva (INCA). Estatísticas de Câncer. 2019.
Bottino SM, Fráguas R, Gattaz WF. Depressão e câncer. Rev psiq clín. 2009;36(3):109-15.
Carvalho SM, Bezerra IM, Freitas TH, Rodrigues RCS, Carvalho IO, Brasil AQ, et al. Prevalência de depressão maior em pacientes com câncer de mama. Rev bras crescimento desenvolv hum. 2015;25(1):68-74.
Ferreira AS, Bicalho BP, Neves LF, Menezes MT, Silva TA, Faier TA, et al. Prevalência de ansiedade e depressão em pacientes oncológicos e identificação de variáveis predisponente. Rev bras cancerol. 2016;62(4):321-28.
Baptista MN, Baptista ASD, Oliveira MG. Depressão e gênero: por que as mulheres deprimem mais que os homens? Temas psicol. 1999;7(2):143-56.
Calais SL, Andrade LM, Lipp ME. Diferenças de sexo e escolaridade na manifestação do stress em adultos jovens. Psicol reflex crit. 2003;16(2):257-63.
Kinrys G, Wygant LE. Anxiety disorders in women: does gender matter to treatment. Rev bras Psiquiatr. 2005;27:43-50.
